Programs, research, and an
active network that orchestrates healthcare innovations from
funding through exit.
Exit Lab™ offers curated and confidential programs that connect early-stage medical device, life sciences, and healthcare technologies with commercialization partners, healthcare administrators, testing houses, subject matter experts, investors, group purchasing organizations, and more.
Subscribe to our newsletter to get
custom research, visibility into new
technologies, and more!
Exit Lab™ Programming
Live Labs
Live Labs are curated and themed events where we invite startups, corporate innovators, potential customers, subject-matter experts, and investors together to meet one another, dive deep, and explore opportunities.
Digital Community & Marketplace
Everyone who has been curated and invited into our community has a home in our digital community! This is where you can connect with each other, crowdsource problems, and work on solutions in a private and confidential setting.
Brokerage and Bespoke Projects
Want to rely on Exit Lab as a trusted third party broker to help you with funding, access to commercialization partners, recruiting, and more. Let our team of experts work our active network for you!
About Exit Lab™
We are founders, inventors, and enthusiasts creating a platform to assist new technologies and businesses as they move from inception to funding to commercialization to adoption, and eventually, exit.
The global healthcare landscape is evolving rapidly, with new technologies poised for large-scale adoption. Often, those on the front lines have the keenest insight into what technologies to develop next. Exit Lab is here to assist everyone in the healthcare innovation supply chain. We aim to be partners with as many organizations as we can, because that's what we believe it takes to bring highly innovative products into our healthcare system.
Who We Serve
2
Corporate Innovators & Commercialization Partners
Your R&D or M&A team is searching for the next major technology that could add hundreds of millions or even billions to your product portfolio. Consider us as a strategic partner in your sourcing and due diligence efforts. We can also customize events and programs just for you!
3
Investors
For high-tech companies with strong IP, FDA clearance often hinges on time and funding to validate their life-changing technology. We aim to reduce funding risks by connecting startups with commercialization partners that can provide legitimacy and a clear market path that will give investors confidence in their potential investments.
"An important part of any medical device is not just how well it works, but when it becomes available to those who need it."
Dean Kamen